These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15381128)

  • 1. More tools for prion research.
    Bradbury J
    Drug Discov Today; 2004 Oct; 9(19):821-2. PubMed ID: 15381128
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in prion immunotherapy.
    Heppner FL; Aguzzi A
    Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.
    Bade S; Frey A
    Expert Rev Vaccines; 2007 Apr; 6(2):153-68. PubMed ID: 17408366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein-specific antibodies-development, modes of action and therapeutics application.
    Rovis TL; Legname G
    Viruses; 2014 Oct; 6(10):3719-37. PubMed ID: 25275428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The continuing quest for a pre-mortem test for TSEs.
    Clewley JP
    Commun Dis Public Health; 2003 Dec; 6(4):352-4. PubMed ID: 15067863
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein-based PCR for prion diseases?
    Telling G
    Nat Med; 2001 Jul; 7(7):778-9. PubMed ID: 11433339
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotoxic species in prion disease: a role for PrP isoforms?
    Harrison CF; Barnham KJ; Hill AF
    J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and animal spongiform encephalopathies are autoimmune diseases: a novel theory and its supporting evidence.
    Zhu BT
    Int Rev Neurobiol; 2005; 63():155-90. PubMed ID: 15797468
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational exposure: a new handle on prions.
    Brown DR
    Lancet; 2003 Sep; 362(9388):929-30. PubMed ID: 14511922
    [No Abstract]   [Full Text] [Related]  

  • 15. Human prion diseases: molecular and clinical aspects.
    Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
    Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.
    Nitschke C; Flechsig E; van den Brandt J; Lindner N; Lührs T; Dittmer U; Klein MA
    Vet Microbiol; 2007 Aug; 123(4):367-76. PubMed ID: 17499458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I; Cardinale A; Mattei S; Biocca S
    J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein conformation dictates prion strain.
    Aguzzi A
    Nat Med; 1998 Oct; 4(10):1125-6. PubMed ID: 9771742
    [No Abstract]   [Full Text] [Related]  

  • 19. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.
    Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S
    Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
    Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
    Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.